ESC 365
Menu
Home
Search
Events
About
ESC Platforms
Escardio.org
ESC 365
ESC eLearning
Create an account
Sign in
Back
Everyday clinical challenges in non-valvular atrial fibrillation and venous thromboembolism: your questions answered.
Session:
The thrombosis versus bleeding risk dilemma: practical considerations with oral factor Xa inhibition
Topic:
Atrial fibrillation (AF)
Speaker:
Professor S. Hohnloser (Frankfurt, DE)
Professor J. Alexander (Durham, US)
Professor G. Agnelli (Perugia, IT)
Sponsored by Bristol-Myers Squibb and Pfizer Alliance
Event:
ESC CONGRESS 2014
About the speakers
Professor Stefan H Hohnloser
Johann Wolfgang Goethe University, Frankfurt (Germany)
30
presentations
1
follower
Professor John Alexander
Duke University Medical Center, Durham (United States of America)
3
presentations
0
follower
Professor Giancarlo Agnelli
University of Perugia, Perugia (Italy)
18
presentations
0
follower
Access the full session
The thrombosis versus bleeding risk dilemma: practical considerations with oral factor Xa inhibition
Speakers:
Professor S. Hohnloser, Professor J. Alexander, Professor G. Agnelli
Access
About the event
ESC CONGRESS 2014
30 August - 3 September 2014
Sessions
Presentations
ESC 365 is supported by